Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Calgary

$17,500.00

Regulation of Macrophage Activity by Interleukin-6

EF 2010-11

Résumé
The two major forms of inflammatory bowel disease (IBD), Crohn's disease and ulcerative colitis, are life-long severely debilitating conditions. Neither the cause nor a cure for IBD is known, and Canada has one of the highest rates of IBD in the world. Although the cause of IBD has not yet been determined, the current consensus is that disease develops in a genetically predisposed individual as an exaggerated or poorly controlled immune response to a component of the normal bacterial flora that resides in the human colon. Focusing on the immune response, the macrophage is an intriguing cell because it will respond directly to bacteria and exert pro-inflammatory or anti-inflammatory effects. Recently, the McKay laboratory has examined a specific sub-set of macrophages, known as alternatively activated macrophages (AAMs). They showed that these cells can reduce the severity of a chemically-induced inflammation in the colons of mice. The precise mechanism(s) by which AAMs reduce colitis remains to be determined. Thus, the focus of my project is to study how the induction and function of AAMs may be influenced by factors commonly present in the intestine. In particular, I will initially focus on the cytokine interleukin (IL)-6, an important molecule involved in cell signaling, which is constitutively produced in the body, and I will test the hypothesis that IL-6 enhances the phenotype and anti-inflammatory activity of AAMs. Subsequently I will delve into the cellular mechanism by which IL-6 affects the AAM, explore the effects of other IL-6 family members on the AAM, and ultimately move from these cell culture analyses to an assessment of AAM activity in murine models of gut disease. The ultimate translational goal of my project is to determine whether autologous transplant of AAMs derived from patients with IBD could serve as a therapy for IBD.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
225511
Name
Fernando Maria R
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
Regulation of Macrophage Activity by Interleukin-6
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Colitis; Gastrointestinal System; Immunology; Inflammatory Bowel Disease; Interleukin-6; Macrophages
Abstract
The two major forms of inflammatory bowel disease (IBD), Crohn's disease and ulcerative colitis, are life-long severely debilitating conditions. Neither the cause nor a cure for IBD is known, and Canada has one of the highest rates of IBD in the world. Although the cause of IBD has not yet been determined, the current consensus is that disease develops in a genetically predisposed individual as an exaggerated or poorly controlled immune response to a component of the normal bacterial flora that resides in the human colon. Focusing on the immune response, the macrophage is an intriguing cell because it will respond directly to bacteria and exert pro-inflammatory or anti-inflammatory effects. Recently, the McKay laboratory has examined a specific sub-set of macrophages, known as alternatively activated macrophages (AAMs). They showed that these cells can reduce the severity of a chemically-induced inflammation in the colons of mice. The precise mechanism(s) by which AAMs reduce colitis remains to be determined. Thus, the focus of my project is to study how the induction and function of AAMs may be influenced by factors commonly present in the intestine. In particular, I will initially focus on the cytokine interleukin (IL)-6, an important molecule involved in cell signaling, which is constitutively produced in the body, and I will test the hypothesis that IL-6 enhances the phenotype and anti-inflammatory activity of AAMs. Subsequently I will delve into the cellular mechanism by which IL-6 affects the AAM, explore the effects of other IL-6 family members on the AAM, and ultimately move from these cell culture analyses to an assessment of AAM activity in murine models of gut disease. The ultimate translational goal of my project is to determine whether autologous transplant of AAMs derived from patients with IBD could serve as a therapy for IBD.
Competitiondate
201102
Approvedterm2
1 yr 0 mth
Pinamesdelim
Fernando, Maria R
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~